Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2006

View Archived Issues

Active first quarter at Novo Nordisk

YM-529 inhibits bladder cancer cell growth

Safety and activity of CG-0070 in recurrent bladder cancer reported

Avanafil effective in men with mild to moderate erectile dysfunction

Study supports once-daily dosing of SLx-2101

Pretrial dosing begins with Conor Medsystems' dual-drug coronary stent

Jerini and Baxter report update on nonintravenous hemophilia therapy program

Novavax and Esprit to codevelop drug for female sexual desire disorder

Zenyth receives fourth milestone payment from Merck under asthma collaboration

Colorectal cancer patients included in phase I/II study of AP-12009

Phase IIa Atrigel/octreotide program in acromegaly delayed

Bavarian Nordic updates smallpox vaccine program

Phase II study begins for MK-0354 in patients with dyslipidemia

Phase II Oxycyte study in traumatic brain injury reaches treatment half-way post

CardioVascular BioTherapeutics achieves safety milestone in phase I heart trial

SRI awarded NIAID contract to produce oral formulations for antiradiation drugs

ConjuChem completes financing

Genzyme testing gene therapy for intermittent claudication

Fast track designation for Nektar's amphotericin B inhalation powder

Studies examine prolonged activity of once-daily tenatoprazole

Alvimopan improves gastrointestinal recovery after small bowel resection

Preclinical studies detail activity of asenapine

Recent patents cover novel analgesic agents

Novel agents for treating neurological disorders disclosed in recent patent literature

Recent patents describe new treatment options for endocrine-related disorders

The alpha7 nicotinic agonist AR-R17779 shows efficacy in a rat model of postoperative ileus

Intestinal inflammation may be reduced with cannabinoid receptor 2 agonists

Inhibition of heat shock protein 90 by KU-36 reduces prostate cancer proliferation

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...